Report Detail
COVID-19 Impact on Global Biologics Drug Development Market Size, Status and Forecast 2020-2026
- RnM3985173 |
- 03 June, 2020 |
- Global |
- 91 Pages |
- QYResearch |
- Other
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics Drug Development market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biologics Drug Development industry.
Based on our recent survey, we have several different scenarios about the Biologics Drug Development YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biologics Drug Development will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Drug Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Drug Development market in terms of revenue.
Players, stakeholders, and other participants in the global Biologics Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biologics Drug Development market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biologics Drug Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Drug Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Drug Development market.
The following players are covered in this report:
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Biologics Drug Development Breakdown Data by Type
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Biologics Drug Development Breakdown Data by Application
In-House
Outsource
Pharma Excess
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Biologics Drug Development Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Clinical Manufacturing
- 1.4.3 Formulation Development
- 1.4.4 Bioassay Development
- 1.4.5 Analytical Services
- 1.5 Market by Application
- 1.5.1 Global Biologics Drug Development Market Share by Application: 2020 VS 2026
- 1.5.2 In-House
- 1.5.3 Outsource
- 1.5.4 Pharma Excess
- 1.6 Coronavirus Disease 2019 (Covid-19): Biologics Drug Development Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biologics Drug Development Industry
- 1.6.1.1 Biologics Drug Development Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biologics Drug Development Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biologics Drug Development Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biologics Drug Development Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Biologics Drug Development Market Perspective (2015-2026)
- 2.2 Biologics Drug Development Growth Trends by Regions
- 2.2.1 Biologics Drug Development Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Biologics Drug Development Historic Market Share by Regions (2015-2020)
- 2.2.3 Biologics Drug Development Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Biologics Drug Development Market Growth Strategy
- 2.3.6 Primary Interviews with Key Biologics Drug Development Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Biologics Drug Development Players by Market Size
- 3.1.1 Global Top Biologics Drug Development Players by Revenue (2015-2020)
- 3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Biologics Drug Development Market Concentration Ratio
- 3.2.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2019
- 3.3 Biologics Drug Development Key Players Head office and Area Served
- 3.4 Key Players Biologics Drug Development Product Solution and Service
- 3.5 Date of Enter into Biologics Drug Development Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biologics Drug Development Historic Market Size by Type (2015-2020)
- 4.2 Global Biologics Drug Development Forecasted Market Size by Type (2021-2026)
5 Biologics Drug Development Breakdown Data by Application (2015-2026)
- 5.1 Global Biologics Drug Development Market Size by Application (2015-2020)
- 5.2 Global Biologics Drug Development Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Biologics Drug Development Market Size (2015-2020)
- 6.2 Biologics Drug Development Key Players in North America (2019-2020)
- 6.3 North America Biologics Drug Development Market Size by Type (2015-2020)
- 6.4 North America Biologics Drug Development Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Biologics Drug Development Market Size (2015-2020)
- 7.2 Biologics Drug Development Key Players in Europe (2019-2020)
- 7.3 Europe Biologics Drug Development Market Size by Type (2015-2020)
- 7.4 Europe Biologics Drug Development Market Size by Application (2015-2020)
8 China
- 8.1 China Biologics Drug Development Market Size (2015-2020)
- 8.2 Biologics Drug Development Key Players in China (2019-2020)
- 8.3 China Biologics Drug Development Market Size by Type (2015-2020)
- 8.4 China Biologics Drug Development Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Biologics Drug Development Market Size (2015-2020)
- 9.2 Biologics Drug Development Key Players in Japan (2019-2020)
- 9.3 Japan Biologics Drug Development Market Size by Type (2015-2020)
- 9.4 Japan Biologics Drug Development Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Biologics Drug Development Market Size (2015-2020)
- 10.2 Biologics Drug Development Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Biologics Drug Development Market Size by Type (2015-2020)
- 10.4 Southeast Asia Biologics Drug Development Market Size by Application (2015-2020)
11 India
- 11.1 India Biologics Drug Development Market Size (2015-2020)
- 11.2 Biologics Drug Development Key Players in India (2019-2020)
- 11.3 India Biologics Drug Development Market Size by Type (2015-2020)
- 11.4 India Biologics Drug Development Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Biologics Drug Development Market Size (2015-2020)
- 12.2 Biologics Drug Development Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Biologics Drug Development Market Size by Type (2015-2020)
- 12.4 Central & South America Biologics Drug Development Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Abbvie
- 13.1.1 Abbvie Company Details
- 13.1.2 Abbvie Business Overview and Its Total Revenue
- 13.1.3 Abbvie Biologics Drug Development Introduction
- 13.1.4 Abbvie Revenue in Biologics Drug Development Business (2015-2020))
- 13.1.5 Abbvie Recent Development
- 13.2 Allergan
- 13.2.1 Allergan Company Details
- 13.2.2 Allergan Business Overview and Its Total Revenue
- 13.2.3 Allergan Biologics Drug Development Introduction
- 13.2.4 Allergan Revenue in Biologics Drug Development Business (2015-2020)
- 13.2.5 Allergan Recent Development
- 13.3 Boehringer Ingelheim
- 13.3.1 Boehringer Ingelheim Company Details
- 13.3.2 Boehringer Ingelheim Business Overview and Its Total Revenue
- 13.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
- 13.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2015-2020)
- 13.3.5 Boehringer Ingelheim Recent Development
- 13.4 Charles River Laboratories
- 13.4.1 Charles River Laboratories Company Details
- 13.4.2 Charles River Laboratories Business Overview and Its Total Revenue
- 13.4.3 Charles River Laboratories Biologics Drug Development Introduction
- 13.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2015-2020)
- 13.4.5 Charles River Laboratories Recent Development
- 13.5 Catalent
- 13.5.1 Catalent Company Details
- 13.5.2 Catalent Business Overview and Its Total Revenue
- 13.5.3 Catalent Biologics Drug Development Introduction
- 13.5.4 Catalent Revenue in Biologics Drug Development Business (2015-2020)
- 13.5.5 Catalent Recent Development
- 13.6 Lonza Group
- 13.6.1 Lonza Group Company Details
- 13.6.2 Lonza Group Business Overview and Its Total Revenue
- 13.6.3 Lonza Group Biologics Drug Development Introduction
- 13.6.4 Lonza Group Revenue in Biologics Drug Development Business (2015-2020)
- 13.6.5 Lonza Group Recent Development
- 13.7 Amgen
- 13.7.1 Amgen Company Details
- 13.7.2 Amgen Business Overview and Its Total Revenue
- 13.7.3 Amgen Biologics Drug Development Introduction
- 13.7.4 Amgen Revenue in Biologics Drug Development Business (2015-2020)
- 13.7.5 Amgen Recent Development
- 13.8 Sanofi
- 13.8.1 Sanofi Company Details
- 13.8.2 Sanofi Business Overview and Its Total Revenue
- 13.8.3 Sanofi Biologics Drug Development Introduction
- 13.8.4 Sanofi Revenue in Biologics Drug Development Business (2015-2020)
- 13.8.5 Sanofi Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Biologics Drug Development. Industry analysis & Market Report on COVID-19 Impact on Global Biologics Drug Development is a syndicated market report, published as COVID-19 Impact on Global Biologics Drug Development Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biologics Drug Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
